Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionFront Row Advisors LLC
Latest Disclosed Ownership1,497 shares
Latest Disclosed Value $ 208,574
Front Row Advisors LLC ownership in GILD / Gilead Sciences, Inc.

On May 19, 2026 - Front Row Advisors LLC filed a 13F-HR form disclosing ownership of 1,497 shares of Gilead Sciences, Inc. (CH:GILD) valued at $208,574 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,497 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-19 2026-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,497 0 0.00 209 13.66 0.0706
2026-02-12 2025-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,497 0 0.00 184 10.24 0.0612
2025-11-17 2025-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,497 -28 -1.84 166 -1.78 0.0558
2025-08-18 2025-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,525 -58 -3.66 169 -4.52 0.0588
2025-05-15 2025-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,583 2 0.13 177 21.23 0.0682
2025-02-12 2024-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,581 0 0.00 146 10.61 0.0505
2024-11-14 2024-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,581 0 0.00 133 22.22 0.0473
2024-08-16 2024-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,581 0 0.00 108 -6.09 0.0377
2024-05-14 2024-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,581 795 101.15 116 82.54 0.0429
2024-02-15 2023-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 786 0 0.00 64 8.62 0.0293
2023-11-15 2023-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 786 0 0.00 59 0.0272
2023-08-15 2023-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 786 0 0.00 0 0.0271
2023-05-23 2023-03-31 13F/A-1 GILEAD SCIENCES INC COM Stock 375558103 786 141 21.86 0 0.0312
2023-05-15 2023-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 65 -580 0 0.0400
2023-02-15 2022-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 645 -141 -17.94 0 -100.00 0.0284
2022-11-16 2022-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 786 1 0.13 49 0.00 0.0254
2022-08-15 2022-06-30 13F GILEAD SCIENCES INC COM STOCK 375558103 785 2 0.26 49 4.26 0.0241
2022-05-11 2022-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 783 2 0.26 47 -17.54 0.0189
2022-03-09 2021-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 781 -249 -24.17 57 -20.83 0.0213
2021-11-03 2021-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,030 1 0.10 72 -2.70 0.0304
2021-08-23 2021-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,029 2 0.19 74 12.12 0.0304
2021-04-28 2021-03-31 13F GILEAD SCIENCES INC COM STOCK 375558103 1,027 1 0.10 66 10.00 0.0320
2021-02-25 2020-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,026 2 0.20 60 -1.64 0.0307
2020-11-30 2020-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,024 -243 -19.18 61 -37.11 0.0323
2020-08-17 2020-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 1,267 1 0.08 97 -8.49 0.0601
2020-05-08 2020-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 1,266 595 88.67 106 140.91 0.0716
2020-02-14 2019-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 671 1 0.15 44 4.76 0.0287
2019-11-08 2019-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 670 -21 -3.04 42 -10.64 0.0299
2019-08-27 2019-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 691 512 286.03 47 291.67 0.0342
2019-05-17 2019-03-31 13F/A-1 GILEAD SCIENCES INC COM Stock 375558103 179 106 145.21 12 140.00 0.0093
2019-05-16 2019-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 73 0 5
2019-02-13 2018-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 73 0 0.00 5 0.00 0.0043
2018-11-13 2018-09-30 13F GILEAD SCIENCES INC COM Stock 375558103 73 -88 -54.66 5 -61.54 0.0035
2018-07-31 2018-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 161 23 16.67 13 30.00 0.0083
2018-05-21 2018-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 138 50 56.82 10 66.67 0.0070
2018-01-31 2017-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 88 88 6 0.0048
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.